T-cell-independent macrophage activation in mice induced with rRNA from Listeria monocytogenes and dimethyldioctadecylammonium bromide.
Purified rRNA from Listeria monocytogenes or Pseudomonas aeruginosa injected in combination with dimethyldioctadecylammonium bromide (DDA), protects mice nonspecifically against a lethal challenge of various extra- and intracellular bacteria. In the present study vaccination of BALB/c as well as C57BL/Ka mice with listerial RNA-DDA resulted in activation of fixed-tissue macrophages, as measured by an enhanced in vivo L. monocytogenes killing in spleen and liver. Evidence was found that macrophage activation by vaccination with rRNA-DDA occurred by a T-cell-independent mechanism. Treatment of mice with cyclosporin A had no effect on the enhanced L. monocytogenes killing induced with RNA-DDA; in vitro exposure of RNA-DDA to spleen cell cultures did not give rise to any lymphocyte proliferation. No evidence could be found for a possible adjuvant activity for RNA-DDA in cellular responses; in fact, RNA-DDA had an inhibitory effect on lymphocyte proliferative responses to Listeria antigen and to concanavalin A.
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D003524:Cyclosporins / Q000494:pharmacology; D005260:Female; D008089:Listeria monocytogenes / Q000276:immunology*; D008099:Liver / Q000382:microbiology; D008213:Lymphocyte Activation; D008262:Macrophage Activation; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D012335:RNA, Ribosomal / Q000494:pharmacology*; D013154:Spleen / Q000382:microbiology; D013601:T-Lymphocytes / Q000502:physiology*; D014611:Vaccination
D000276:Adjuvants, Immunologic; D003524:Cyclosporins; D000644:Quaternary Ammonium Compounds; D012335:RNA, Ribosomal; C015831:dimethyldioctadecylammonium